Cargando…
Historical and projected public spending on drugs for rare diseases in Canada between 2010 and 2025
OBJECTIVE: Rare diseases are life-threatening, debilitating, or serious chronic conditions that affect < 50/100,000 people. Canadians can only access approximately 60% of drugs for rare diseases (DRDs), which is partially related to high per-patient costs and payers’ affordability concerns. Howev...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548177/ https://www.ncbi.nlm.nih.gov/pubmed/36209128 http://dx.doi.org/10.1186/s13023-022-02534-z |